S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17

Bionik Laboratories (BNKL) Stock Forecast, Price & News

0.00 (0.00%)
(As of 05/17/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume
50 shs
Market Capitalization
$2.90 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BNKL News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Bionik Laboratories logo

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND for therapy involving reaching with grasp and release movements, and individual hand movements; InMotion Connect, a solution to meet the data connectivity and analytics needs of hospitals and healthcare facilities; and InMotion Wrist. The company also engages in developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; and ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other mobility disabilities. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.19 million
Book Value
$0.58 per share


Net Income
$-13.62 million
Net Margins
Pretax Margin




Free Float
Market Cap
$2.90 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

1.34 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Bionik Laboratories (OTCMKTS:BNKL) Frequently Asked Questions

Who are Bionik Laboratories' key executives?
Bionik Laboratories' management team includes the following people:
  • Mr. Richard Paul Russo Jr., CPA, CFO & Interim CEO (Age 41, Pay $265.82k)
  • Mr. Michal Prywata, Co-Founder & Director (Age 31, Pay $169.97k)
  • Mr. Loren W. Wass, Chief Commercial Officer (Age 60, Pay $259.54k)
Who are some of Bionik Laboratories' key competitors?
What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include Co-Diagnostics (CODX), iBio (IBIO), PerkinElmer (PKI), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY).

What is Bionik Laboratories' stock symbol?

Bionik Laboratories trades on the OTCMKTS under the ticker symbol "BNKL."

How do I buy shares of Bionik Laboratories?

Shares of BNKL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bionik Laboratories' stock price today?

One share of BNKL stock can currently be purchased for approximately $0.50.

How much money does Bionik Laboratories make?

Bionik Laboratories has a market capitalization of $2.90 million and generates $1.19 million in revenue each year. The company earns $-13.62 million in net income (profit) each year or ($1.680010) on an earnings per share basis.

How many employees does Bionik Laboratories have?

Bionik Laboratories employs 13 workers across the globe.

What is Bionik Laboratories' official website?

The official website for Bionik Laboratories is www.bioniklabs.com.

How can I contact Bionik Laboratories?

Bionik Laboratories' mailing address is 483 Bay Street N105, Toronto A6, M5G2C9. The company can be reached via phone at 617-926-4800 or via email at [email protected].

This page was last updated on 5/18/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.